Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study-Reference-Cited by-同舟云学术

Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study

Published:2018-06-01 Issue:6 Volume:13 Page:e0198006
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

van Geel Tineke A. C. M.^ORCID,Bliuc Dana,Geusens Piet P. M.,Center Jacqueline R.,Dinant Geert-Jan,Tran Thach,van den Bergh Joop P. W.,McLellan Alastair R.,Eisman John A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromso, Norway;LA Ahmed;Eur J Epidemiol,2009

2. Estimation of the lifetime risk of hip fracture for women and men in Canada;RB Hopkins;Osteoporos Int,2012

3. Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES);G Jones;Osteoporos Int,1994

4. Residual lifetime risk of fractures in women and men;ND Nguyen;J Bone Miner Res,2007

5. Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle;K Akesson;Osteoporos Int,2013

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Bisphosphonate Therapy Reduce Overall Mortality in Patients With Osteoporosis? A Meta-analysis of Randomized Controlled Trials;Clinical Orthopaedics & Related Research;2024-08-22

2. Zoledronic acid for hip fracture during initial hospitalization;Journal of Bone and Mineral Research;2024-07-02

3. Safe prescribing of oral alendronic acid following hip fracture;International Journal for Advancing Practice;2024-04-02

4. Duration of osteoporosis treatment to reduce the risk of subsequent osteoporotic fracture and all-cause mortality in elderly hip fracture patients in a Korean real-world study;Archives of Osteoporosis;2024-01-10

5. Denosumab and Mortality in a Real‐World Setting: A Comparative Study;Journal of Bone and Mineral Research;2023-12